Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
154 studies found for:    Hyponatraemia
Show Display Options
Rank Status Study
1 Withdrawn Fractional Urate Excretion in Nonedematous Hyponatremia
Conditions: Cerebral Hyponatremia;   SIADH;   Cerebral Salt-wasting Syndrome;   Reset Hypothalamic Osmostat
Intervention: Drug: Tolvaptan in euvolemic hyponatremia
2 Completed Institutional Registry of Hyponatremia
Condition: Hyponatremia
Intervention:
3 Completed Relationship Between Heat Wave and Hyponatremia
Condition: Hyponatremia
Intervention: Other: Seasonality
4 Completed Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia
Conditions: Euvolemic Hyponatremia;   Hypervolemic Hyponatremia
Intervention:
5 Completed A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Safety and Tolerability of Oral Lixivaptan Capsules in Subjects With Euvolemic Hyponatremia
Condition: Euvolemic Hyponatremia
Interventions: Drug: Lixivaptan;   Drug: Placebo
6 Completed Post Operative Hyponatremia in the Renal Transplant Population
Condition: Hyponatremia
Intervention:
7 Completed Incidence of Hyponatremia in PEG-SD Compared to PEG-ELS
Condition: Hyponatremia
Interventions: Drug: PEG-SD;   Drug: PEG-ELS
8 Not yet recruiting Factors Associated With Hyponatremia Induced by High-dose Cyclophosphamide
Condition: Hyponatremia
Intervention:
9 Recruiting Characterisation of Neuropsychological and Motoric Performance in Patients With Hyponatremia
Condition: Hyponatremia
Intervention: Other: Neuropsychological and motoric tests
10 Completed Effects of Empagliflozin an SGLT2-Inhibitor on Healthy Volunteers With Induced Hypotonic Hyponatremia - the DIVE Study
Condition: Inappropriate ADH Syndrome
Interventions: Other: Induced hypotonic hyponatremia - SIAD model;   Drug: Empagliflozin 25mg Tbl;   Drug: Placebo P-Tablet
11 Unknown  Radiocontrast Media Induced Hyponatremia
Condition: Percutaneous Coronary Intervention
Intervention:
12 Completed
Has Results
International, Multicenter, Study of One-year, Open-label, Titrated Oral Tolvaptan Tablet Administration in Patients With Chronic Hyponatremia
Condition: Hyponatremia
Intervention: Drug: Tolvaptan
13 Completed THE BALANCE Study: Treatment of Hyponatremia Based on Lixivaptan in NYHA Class III/IV Cardiac Patient Evaluation
Condition: Hyponatremia
Interventions: Drug: lixivaptan;   Drug: Placebo
14 Completed Use of Isotonic Solutions Versus Hypotonic Solutions for Preventing Hospital Acquired Hyponatremia
Condition: Hyponatremia
Interventions: Drug: 0.3% Saline in 3.3% dextrose;   Drug: 0.45% Saline in 5% dextrose;   Drug: 0.9% Saline in 5% dextrose
15 Terminated Tolvaptan for In-hospital Hyponatremia
Condition: Hyponatremia.
Interventions: Drug: Tolvaptan;   Other: Standard therapy
16 Recruiting Protein Supplementation in Thiazide-induced Hyponatremia
Conditions: Hyponatremia;   Hypertension;   Blood Pressure
Intervention: Dietary Supplement: Nepro
17 Completed Bioimpedance Spectroscopy for the Differential Diagnosis of Hyponatremia
Condition: Hyponatremia
Intervention:
18 Completed Polymorphisms of the Thiazide's Receptor Gene SLC12A3 and Development of Hyponatremia
Condition: Thiazide Diuretics Induced Hyponatremia
Intervention:
19 Withdrawn Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients
Condition: Hyponatremia
Interventions: Drug: Conivaptan;   Other: D5
20 Completed Hyponatremia in the Elderly: Benefit From a Change in Drug Therapy?
Condition: Hyponatremia
Intervention: Other: change in drug therapy

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.